• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Mayne Pharma Group Ltd

+ Add to Watchlist

HG6:GR

0.555 EUR 0.010 1.83%

As of 02:12:03 ET on 08/22/2014.

Snapshot for Mayne Pharma Group Ltd (HG6)

Open: 0.554 Day's Range: 0.554 - 0.555 Volume: 0
Previous Close: 0.545 52wk Range: 0.340 - 0.666 1-Yr Rtn: +53.74%

Stock Chart for HG6

No chart data available.
  • HG6:GR 0.554
  • 1D
  • 1M
  • 1Y
0.545
Interactive HG6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HG6

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 26.3122
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) 0.0300
Est. PEG Ratio 0.8461
Market Cap (M EUR) 325.59
Shares Outstanding (M) 586.65
30 Day Average Volume 8
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (AUD) 0.0078
Dividend Ex-Date 03/03/2011
5 Year Dividend Growth -
Next Earnings Announcement 08/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HG6

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for HG6

Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.

Scott RichardsMng Dir/CEO/Exec DirMark CansdaleCFO/Secretary
Danny DragovicDirector:Business Development
More Company Profile & Key Executives for HG6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil